MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2008.06.029

Медицинская библиотека · American heart journal · 2008

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.

Goto Shinya, Bhatt Deepak L, Röther Joachim, Alberts Mark, Hill Michael D, Ikeda Yasuo, Uchiyama Shinichiro, D'Agostino Ralph, Ohman E Magnus, Liau Chiau-Suong, Hirsch Alan T, Mas Jean-Louis, Wilson Peter W F, Corbalán Ramón, Aichner Franz, Steg P Gabriel, REACH Registry Investigators

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Atrial fibrillation (AF) is a major risk factor (RF) for ischemic stroke. Its prevalence and prognostic impact in patients with atherothrombosis are unclear.

METHODS

Risk factors, drug usage, and 1-year cardiovascular (CV) outcomes (CV death, myocardial infarction [MI], and stroke) were compared in AF and non-AF patients from the REduction of Atherothrombosis for Continued Health (REACH) Registry, an international, prospective cohort of 68,236 stable outpatients with established atherothrombosis or>or=3 atherothrombotic RFs.

RESULTS

Atrial fibrillation and 1-year follow-up data are available for 63,589 patients. The prevalence of AF was, 12.5%, 13.7%, 11.5%, and 6.2% among coronary artery disease, CV disease, peripheral artery disease, and RF-only patients, respectively. Of the 6,814 patients with AF, 6.7% experienced CV death, nonfatal MI, or nonfatal stroke within a year. The annual incidence of nonfatal stroke (2.4% vs 1.6%, P<.0001) and unstable angina (6.0% vs 4.0%, P<.00001) was higher, and CV death was more than double (3.2% vs 1.4%, P<.0001), in AF versus non-AF patients. In these patients with or at high risk of atherothrombosis, most patients with AF received antiplatelet agents, but only 53.1% were treated with oral anticoagulants. Even with high CHADS2 (congestive heart failure, hypertension, aging, diabetes mellitus, and stroke) scores, anticoagulant use did not exceed (59%). The rate of bleeding requiring hospitalization was higher in AF versus non-AF patients (1.5% vs 0.8%, P<.0001), possibly related to the more frequent use of anticoagulants (53.1% vs 7.1%).

CONCLUSIONS

Atrial fibrillation is common in patients with atherothrombosis, associated with more frequent fatal and nonfatal CV outcomes, and underuse of oral anticoagulants.

Для цитирования: Goto Shinya, Bhatt Deepak L, Röther Joachim, Alberts Mark, Hill Michael D, Ikeda Yasuo, Uchiyama Shinichiro, D'Agostino Ralph, Ohman E Magnus, Liau Chiau-Suong, Hirsch Alan T, Mas Jean-Louis, Wilson Peter W F, Corbalán Ramón, Aichner Franz, Steg P Gabriel, REACH Registry Investigators. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.. American heart journal. 2008. DOI: 10.1016/j.ahj.2008.06.029.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.